General practitioners’ deprescribing decisions in older adults with polypharmacy: a case vignette study in 31 countries

[1]  M. Rich,et al.  Physician Perspectives on Deprescribing Cardiovascular Medications for Older Adults , 2020, Journal of the American Geriatrics Society.

[2]  Tariq M. Alhawassi,et al.  Prevalence of potentially inappropriate medications use among older adults and risk factors using the 2015 American Geriatrics Society Beers criteria , 2019, BMC Geriatrics.

[3]  K. Alexander,et al.  Deprescribing in Older Adults With Cardiovascular Disease. , 2019, Journal of the American College of Cardiology.

[4]  N. Herrmann,et al.  Deprescribing cholinesterase inhibitors and memantine in dementia: guideline summary , 2019, The Medical journal of Australia.

[5]  N. Rodondi,et al.  Patient Characteristics and General Practitioners’ Advice to Stop Statins in Oldest-Old Patients: a Survey Study Across 30 Countries , 2019, Journal of General Internal Medicine.

[6]  P. Zed.  Deprescribing Proton Pump Inhibitors. , 2018, The Canadian journal of hospital pharmacy.

[7]  R. Collins,et al.  Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus , 2018, The New England journal of medicine.

[8]  A. Pottegård,et al.  Tools for Deprescribing in Frail Older Persons and Those with Limited Life Expectancy: A Systematic Review , 2018, Journal of the American Geriatrics Society.

[9]  N. Rodondi,et al.  How general practitioners would deprescribe in frail oldest-old with polypharmacy — the LESS study , 2018, BMC Family Practice.

[10]  D. Rolfson,et al.  Identification and management of frailty in the primary care setting , 2018, Canadian Medical Association Journal.

[11]  Elsdon Storey,et al.  Effect of Aspirin on All‐Cause Mortality in the Healthy Elderly , 2018, The New England journal of medicine.

[12]  P. Rothwell,et al.  Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial , 2018, The Lancet.

[13]  R. Abdulah,et al.  Polypharmacy leads to increased prevalence of potentially inappropriate medication in the Indonesian geriatric population visiting primary care facilities , 2018, Therapeutics and clinical risk management.

[14]  T. Maeno,et al.  Potentially inappropriate medications with polypharmacy increase the risk of falls in older Japanese patients: 1‐year prospective cohort study , 2018, Geriatrics & gerontology international.

[15]  V. Welch,et al.  Deprescribing benzodiazepine receptor agonists: Evidence-based clinical practice guideline. , 2018, Canadian family physician Medecin de famille canadien.

[16]  K. Johnell,et al.  The epidemiology of polypharmacy in older adults: register-based prospective cohort study , 2018, Clinical epidemiology.

[17]  S. Purdy,et al.  Frailty assessment in primary health care and its association with unplanned secondary care use: a rapid review , 2018, BJGP open.

[18]  V. Welch,et al.  Deprescribing antihyperglycemic agents in older persons: Evidence-based clinical practice guideline. , 2017, Canadian family physician Medecin de famille canadien.

[19]  K. Wallis,et al.  Swimming Against the Tide: Primary Care Physicians’ Views on Deprescribing in Everyday Practice , 2017, The Annals of Family Medicine.

[20]  B. Sibbald.  Reducing inappropriate prescribing easier said than done , 2017, Canadian Medical Association Journal.

[21]  K. Rockwood,et al.  Pharmacokinetic and pharmacodynamic alterations in older people with dementia , 2017, Expert opinion on drug metabolism & toxicology.

[22]  N. Rodondi,et al.  Variation in GP decisions on antihypertensive treatment in oldest-old and frail individuals across 29 countries , 2017, BMC Geriatrics.

[23]  P. Denormandie,et al.  Polypharmacy and potentially inappropriate medications: a cross-sectional analysis among 451 nursing homes in France , 2017, European Journal of Clinical Pharmacology.

[24]  I. Scott,et al.  Negotiating “Unmeasurable Harm and Benefit”: Perspectives of General Practitioners and Consultant Pharmacists on Deprescribing in the Primary Care Setting , 2017, Qualitative health research.

[25]  P. Kearney,et al.  Challenges of deprescribing in the multimorbid patient , 2016, European journal of hospital pharmacy. Science and practice.

[26]  R. Lindley,et al.  Factors influencing deprescribing for residents in Advanced Care Facilities: insights from General Practitioners in Australia and Sweden , 2016, BMC Family Practice.

[27]  H. Valtonen,et al.  A Systematic Review of the Impact of Potentially Inappropriate Medication on Health Care Utilization and Costs Among Older Adults , 2016, Medical care.

[28]  S. Hilmer,et al.  Beliefs and attitudes of older adults and carers about deprescribing of medications: a qualitative focus group study. , 2016, The British journal of general practice : the journal of the Royal College of General Practitioners.

[29]  M. Numans,et al.  Deprescribing Potentially Inappropriate Preventive Cardiovascular Medication , 2016, The Annals of pharmacotherapy.

[30]  J. Long,et al.  A systematic review of the emerging definition of 'deprescribing' with network analysis: implications for future research and clinical practice. , 2015, British journal of clinical pharmacology.

[31]  D. Ní Chróinín,et al.  Factors influencing deprescribing habits among geriatricians. , 2015, Age and ageing.

[32]  Danijela Gnjidic,et al.  Reducing inappropriate polypharmacy: the process of deprescribing. , 2015, JAMA internal medicine.

[33]  C. Bradley,et al.  What to give the patient who has everything? A qualitative study of prescribing for multimorbidity in primary care. , 2015, The British journal of general practice : the journal of the Royal College of General Practitioners.

[34]  I. Scott,et al.  Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis , 2014, BMJ Open.

[35]  M. Wiese,et al.  The benefits and harms of deprescribing , 2014, The Medical journal of Australia.

[36]  K. Yaffe,et al.  Long-term cognitive and functional effects of potentially inappropriate medications in older women. , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.

[37]  Christopher Frank.  Deprescribing: a new word to guide medication review , 2014, Canadian Medical Association Journal.

[38]  M. Wiese,et al.  Patient Barriers to and Enablers of Deprescribing: a Systematic Review , 2013, Drugs & Aging.

[39]  D. L. Le Couteur,et al.  Thinking through the medication list - appropriate prescribing and deprescribing in robust and frail older patients. , 2012, Australian family physician.

[40]  F. Haaijer-Ruskamp,et al.  Deprescribing medication in very elderly patients with multimorbidity: the view of Dutch GPs. A qualitative study , 2012, BMC Family Practice.

[41]  G. Eysenbach.  Correction: Improving the Quality of Web Surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES) , 2012, Journal of Medical Internet Research.

[42]  Paul Gallagher,et al.  Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients. , 2011, Archives of internal medicine.

[43]  R. Sulkava,et al.  Association of polypharmacy with nutritional status, functional ability and cognitive capacity over a three‐year period in an elderly population , 2011, Pharmacoepidemiology and drug safety.

[44]  L. Fried,et al.  A pharmacoepidemiologic study of community-dwelling, disabled older women: Factors associated with medication use. , 2010, The American journal of geriatric pharmacotherapy.

[45]  L. Ring,et al.  GPs' perceptions of multiple-medicine use in older patients. , 2010, Journal of evaluation in clinical practice.

[46]  J. Hirdes,et al.  Risk Factors for Falling Among Community-Based Seniors , 2009, Journal of patient safety.

[47]  C. Mussi,et al.  Potentially Inappropriate Medications and Functional Decline in Elderly Hospitalized Patients , 2009, Journal of the American Geriatrics Society.

[48]  J. Hanlon,et al.  Clinically important drug-disease interactions and their prevalence in older adults. , 2006, Clinical therapeutics.

[49]  Julia K. Nguyen,et al.  Polypharmacy as a risk factor for adverse drug reactions in geriatric nursing home residents. , 2006, The American journal of geriatric pharmacotherapy.

[50]  J. Hanlon,et al.  Potential Drug—Disease Interactions in Frail, Hospitalized Elderly Veterans , 2005, The Annals of pharmacotherapy.

[51]  Gunther Eysenbach,et al.  Improving the Quality of Web Surveys: The Checklist for Reporting Results of Internet E-Surveys (CHERRIES) , 2004, Journal of medical Internet research.

[52]  E. Kaner,et al.  General practice postal surveys: a questionnaire too far? , 1996, BMJ.

[53]  V. Welch,et al.  Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia: Evidence-based clinical practice guideline. , 2018, Canadian family physician Medecin de famille canadien.

[54]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..